In up to 70% of patients, corticosteroids could be tapered or even stopped, confirming the role of anti-TNF-α as efficient corticosteroid-sparing agents even in cases of refractory or aggressive neurosarcoidosis (9, 27). Here, TNF is linked to neurosarcoidosis.